New antidote for blood thinner shows promise in early trial
NCT ID NCT03172910
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 27 times
Summary
This study tested an investigational drug called ciraparantag to see if it can quickly reverse the effects of the blood thinner rivaroxaban. Sixty-nine healthy adults aged 50 to 75 took rivaroxaban and then received either ciraparantag or a placebo. The main goal was to measure how well and how fast the drug restored normal blood clotting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Frontage Clinical Services Inc.
Secaucus, New Jersey, 07094, United States
Conditions
Explore the condition pages connected to this study.